03:26 AM EDT, 08/22/2024 (MT Newswires) -- Richard E Lowenthal, 10% Owner, Director, President and Chief Executive Officer, on August 20, 2024, sold 100,000 shares in ARS Pharmaceuticals ( SPRY ) for $1,502,587. Following the Form 4 filing with the SEC, Lowenthal has control over a total of 10,668,153 shares of the company, with 4,315,313 shares held directly and 6,352,840 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1671858/000141588924021877/xslF345X05/form4-08212024_100821.xml

Price: 13.32, Change: -0.08, Percent Change: -0.60